共 36 条
- [36] Switching from didanosine buffered tablets (Videx®) or generic ddI) to enteric coated capsules (Videx EC®) in HIV-1 infected patients controlled by highly active antiretroviral therapy:: Preliminary report of patients that completed 24 weeks of follow-up XIV INTERNATIONAL AIDS CONFERENCE: CLINICAL SCIENCES AND CARE, 2002, : 271 - 275